Related Experiment Videos
Platelet-activating factor mediated effects on human neutrophil function are inhibited by pertussis toxin
Biochemical and Biophysical Research Communications
|June 28, 1985
Summary
Pertussis toxin blocks platelet-activating factor (PAF) effects on human neutrophils, including movement and enzyme release. This suggests a pertussis toxin-sensitive GTP-binding protein, likely "Ni", mediates PAF actions.
Area of Science:
- Immunology
- Cellular Biology
- Biochemistry
Background:
- Platelet-activating factor (PAF) is a potent lipid mediator involved in inflammation and immune responses.
- Human neutrophils play a critical role in innate immunity and inflammatory processes.
- Pertussis toxin is known to affect various cellular signaling pathways.
Purpose of the Study:
- To investigate the role of pertussis toxin-sensitive signaling pathways in mediating the effects of platelet-activating factor (PAF) on human neutrophils.
- To identify potential targets of pertussis toxin involved in PAF-induced neutrophil activation.
Main Methods:
- Human neutrophils were pretreated with pertussis toxin.
- Neutrophil functions including chemotaxis, superoxide generation, aggregation, and lysozyme release were measured.
- Superoxide generation induced by phorbol-12-myristate-13 acetate (PMA) was assessed as a control.
Main Results:
- Pertussis toxin pretreatment significantly inhibited PAF-mediated chemotaxis, superoxide generation, aggregation, and lysozyme release in human neutrophils.
- Superoxide generation induced by PMA was not affected by pertussis toxin pretreatment, indicating pathway specificity.
- These findings implicate a role for a pertussis toxin-sensitive signaling pathway in PAF-induced neutrophil responses.
Conclusions:
- A target protein for pertussis toxin, likely a GTP-binding protein designated "Ni", is involved in mediating the cellular actions of platelet-activating factor on human neutrophils.
- This study highlights the importance of G-protein coupled receptors and downstream signaling in PAF-induced neutrophil activation.